Literature DB >> 33494637

Treatment and Outcome in Stroke Patients With Acute M2 Occlusion and Minor Neurological Deficits.

Pasquale Mordasini1, Mirjam R Heldner2, Tomas Dobrocky1, Eike I Piechowiak1, Bastian Volbers2,3, Nedelina Slavova1,4, Johannes Kaesmacher1,4, Thomas R Meinel2, Marcel Arnold2, Urs Fischer2, Simon Jung2, Jan Gralla1.   

Abstract

BACKGROUND AND
PURPOSE: Treatment in stroke patients with M2 segment occlusion of the middle cerebral artery presenting with mild neurological deficits is a matter of debate. The main purpose was to compare the outcome in patients with a minor stroke and a M2 occlusion.
METHODS: Consecutive intravenous thrombolysis (IVT) eligible patients admitted to the Bernese stroke center between January 2005 and January 2020 with acute occlusion of the M2 segment and National Institutes of Health Stroke Scale score ≤5 were included. Outcome was compared between IVT only versus endovascular therapy (EVT) including intra-arterial thrombolysis and mechanical thrombectomy (MT; ±IVT) and between IVT only versus MT only.
RESULTS: Among 169 patients (38.5% women, median age 70.2 years), 84 (49.7%) received IVT only and 85 (50.3%) EVT (±IVT), the latter including 39 (45.9%) treated with MT only. Groups were similar in sex, age, vascular risk factors, event cause, or preevent independency. Compared with IVT only, there was no difference in favorable outcome (modified Rankin Scale score, 0-2) for EVT (adjusted odds ratio, 0.96; adjusted P=0.935) or for MT only (adjusted odds ratio, 1.12; adjusted P=0.547) groups. Considering only patients treated after 2015, there was a significantly better 3-month modified Rankin Scale shift (adjusted P=0.032) in the EVT compared with the IVT only group.
CONCLUSIONS: Our study demonstrates similar effectiveness of IVT only versus EVT (±IVT), and of IVT only versus MT only in patients with peripheral middle cerebral artery occlusions and minor neurological deficits and indicates a possible benefit of EVT considering only patients treated after 2015. There is an unmet need for randomized controlled trials in this stroke field, including imaging parameters, and more sophisticated evaluation of National Institutes of Health Stroke Scale score subitems, neurocognition, and quality of life neglected by the standard outcome scales such as modified Rankin Scale and National Institutes of Health Stroke Scale score.

Entities:  

Keywords:  National Institutes of Health; middle cerebral artery; quality of life; risk factors; thrombectomy

Mesh:

Substances:

Year:  2021        PMID: 33494637     DOI: 10.1161/STROKEAHA.120.031672

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  3 in total

1.  Predictors and Impact of Sulcal SAH after Mechanical Thrombectomy in Patients with Isolated M2 Occlusion.

Authors:  D Y Kim; S H Baik; C Jung; J Y Kim; S-G Han; B J Kim; J Kang; H-J Bae; J H Kim
Journal:  AJNR Am J Neuroradiol       Date:  2022-07-28       Impact factor: 4.966

2.  Streamlining Acute Stroke Care by Introducing National Institutes of Health Stroke Scale in the Emergency Medical Services: A Prospective Cohort Study.

Authors:  Karianne Larsen; Henriette S Jæger; Maren R Hov; Kjetil Thorsen; Volker Solyga; Christian G Lund; Kristi G Bache
Journal:  Stroke       Date:  2022-03-16       Impact factor: 10.170

3.  Minor stroke in large vessel occlusion: A matched analysis of patients from the German Stroke Registry-Endovascular Treatment (GSR-ET) and patients from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register (SITS-ISTR).

Authors:  Katharina Feil; Marius Matusevicius; Moriz Herzberg; Steffen Tiedt; Clemens Küpper; Johannes Wischmann; Sonja Schönecker; Annerose Mengel; Jennifer Sartor-Pfeiffer; Katharina Berger; Konstantin Dimitriadis; Thomas Liebig; Marianne Dieterich; Michael Mazya; Niaz Ahmed; Lars Kellert
Journal:  Eur J Neurol       Date:  2022-02-19       Impact factor: 6.288

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.